Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JYHB2101558	多替阿巴拉米片	abacavir sulfate;dolutegravir sodium;lamivudine	Tablet	Chemical Drugs	Supplementary Application	2021-11-26					view
JYHB2400146	多替阿巴拉米片	abacavir sulfate;dolutegravir sodium;lamivudine	Tablet	Chemical Drugs	Supplementary Application	2024-04-03					view
JYHZ2100751	多替阿巴拉米片	abacavir sulfate;dolutegravir sodium;lamivudine	Tablet	Chemical Drugs	License Renew	2022-01-04					view
JYHB2300628	多替阿巴拉米片	abacavir sulfate;dolutegravir sodium;lamivudine	Tablet	Chemical Drugs	Supplementary Application	2023-11-03					view
JYHB2101452	多替阿巴拉米片	abacavir sulfate;dolutegravir sodium;lamivudine	Tablet	Chemical Drugs	Supplementary Application	2021-10-11					view
JYHB2300326	多替阿巴拉米片	abacavir sulfate;dolutegravir sodium;lamivudine	Tablet	Chemical Drugs	Supplementary Application	2023-06-01					view
JYHB2200123	多替阿巴拉米片	abacavir sulfate;dolutegravir sodium;lamivudine	Tablet	Chemical Drugs	Supplementary Application	2022-03-07					view
JYHB2100129	多替阿巴拉米片	abacavir sulfate;dolutegravir sodium;lamivudine	Tablet	Chemical Drugs	Supplementary Application	2021-02-06	葛兰素史克（中国）投资有限公司	GlaxoSmithKline (China) Investment Co Ltd	In Review	2021-02-05	view
JXHL1500238	多替阿巴拉米片	abacavir sulfate;dolutegravir sodium;lamivudine	Tablet	Chemical Drugs	Import Drug Application	2015-09-18	葛兰素史克（中国）投资有限公司	GlaxoSmithKline (China) Investment Co Ltd	Certificate Issued	2016-09-26	view
JYHB2001114	多替阿巴拉米片	abacavir sulfate;dolutegravir sodium;lamivudine	Tablet	Chemical Drugs	Supplementary Application	2020-06-28	葛兰素史克（中国）投资有限公司	GlaxoSmithKline (China) Investment Co Ltd	Filed	2020-06-30	view
JYHB1900197	多替阿巴拉米片	abacavir sulfate;dolutegravir sodium;lamivudine	Tablet	Chemical Drugs	Supplementary Application	2019-03-11	葛兰素史克（中国）投资有限公司	GlaxoSmithKline (China) Investment Co Ltd	Certificate Issued	2019-09-10	view
JXHS1600077	多替阿巴拉米片	abacavir sulfate;dolutegravir sodium;lamivudine	Tablet	Chemical Drugs(5.1)	Import Drug Application	2017-01-20	葛兰素史克（中国）投资有限公司	GlaxoSmithKline (China) Investment Co Ltd	Certificate Issued	2017-08-01	view